Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Propranolol hydrochloride gel for treating infant superficial hemangioma

The technology of propranolol hydrochloride gel and propranolol hydrochloride, which is applied in the field of medicine, can solve the problems of unclear treatment mechanism, apoptosis of vascular endothelial cells, etc., and achieves avoiding adverse reactions, convenient administration and simple preparation. Effect

Active Publication Date: 2013-01-16
XIANGYA HOSPITAL CENT SOUTH UNIV
View PDF2 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although its therapeutic mechanism is not yet clear, it may be related to reducing the release of NO to constrict blood vessels, blocking the signaling pathway of angiogenesis, or inducing apoptosis of vascular endothelial cells, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Propranolol hydrochloride gel for treating infant superficial hemangioma
  • Propranolol hydrochloride gel for treating infant superficial hemangioma
  • Propranolol hydrochloride gel for treating infant superficial hemangioma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] Prepare the gel according to the following prescription (calculated as 100g): PPL·HCl 3g, hydroxypropyl methylcellulose 3g, geraniol 5g, propylene glycol 10g, Tween-601.0g, ethyl paraben 1.0g, the balance is Distilled water.

Embodiment 2

[0057] The gel was prepared according to the following prescription (calculated as 100g): PPL·HCl 6g, hydroxypropyl methylcellulose 3g, geraniol 5g, propylene glycol 10g, Tween-601.0g, ethyl paraben 1.0g, the balance is Distilled water.

Embodiment 3

[0059] The gel was prepared according to the following prescription (calculated as 100g): PPL·HCl 10g, sodium carboxymethyl cellulose 3g, geraniol 5g, propylene glycol 10g, Tween-601.0g, ethyl paraben 1.0g, the balance is distilled water .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines, and provides a propranolol hydrochloride (PPL.HCL) gel which can be externally used for treating infant superficial hemangioma. The propranolol hydrochloride gel is mainly prepared from propranolol hydrochloride, gel matrix, a percutaneous penetration enhancer, a preservative, a humectant and the like. By using the propranolol hydrochloride gel, adverse reactions such as decreased heart rate, cyanosis, airway hyperresponsiveness, shortage of granular leukocytes, diarrhoea, sleep change and blood sugar reduction caused by orally taking propranolol by hemangioma patients can be reduced and even avoided, and the problems that oral dosage is not easy to control, infants inconveniently take medicines and the like are solved.

Description

Technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to a gel for external use using propranolol hydrochloride (PPL·HCl) as an active ingredient. Background technique [0002] Infantile hemangioma (IH) is a kind of congenital dysplasia that occurs during the embryonic blood vessel formation. It is more common at birth or shortly after birth. It is the most common benign tumor in infants and young children. The incidence rate in newborns is 2% to 3%, the incidence rate in children under 1 year is about 10%, and the incidence rate in preterm infants or low birth weight newborns can be as high as 22% to 30%. It usually occurs on the head, neck, trunk and other body surface parts, which affects the appearance, and is often adjacent to important organs, affecting physiological functions or even life-threatening. Early treatment should be actively carried out to control growth and promote regression. There are many traditional treat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K31/138A61K47/10A61K47/08A61P35/00
Inventor 陈翔丁劲松张江林
Owner XIANGYA HOSPITAL CENT SOUTH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com